文献速递认知障碍与痴呆

阿尔茨海默病的临床病理异质性与胶质细胞激活模式

Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease.
PubMed 文献 · JAMA Neurol · 2024-01-01

基于FLAME尸检队列1361例阿尔茨海默病(AD)病例的横断面回顾性病历分析,采用皮质边缘指数(CLix)量化缠结分布。较低CLix与较年轻起病、更快认知下降、非遗忘型综合征及更低的CD68激活小胶质细胞/巨噬细胞负担相关,提示tau累积与胶质激活的关联应考虑于个体化免疫调节治疗。

要点

  • AD异质性沿皮质边缘缠结分布连续体存在,CLix较低者起病更年轻、认知下降更快。
  • 非遗忘型综合征患者CLix中位数13,低于遗忘型患者的21。
  • CLix<10者CD68激活小胶质细胞/巨噬细胞负担中位数0.46%,低于CLix 10-30者的0.75%。

核心结论

  • AD异质性沿皮质边缘缠结分布连续体存在,较低的CD68负担可能提示tau累积与小胶质细胞/巨噬细胞激活之间存在尚未充分认识的关联,个体化免疫失调治疗时应予考虑。

研究设计与样本

  • 横断面研究,对FLAME队列1991年至2020年入组的尸检个体进行回顾性病历分析,数据于2022年12月至2023年12月分析。
  • FLAME队列共2809例尸检个体,纳入神经病理诊断的AD病例1361例(FLAME-AD),数字病理亚组60例,独立神经影像组93例。

主要发现

  • 1361例FLAME-AD中,男性633例(47%,死亡年龄中位数[范围]81[54-96]岁),女性728例(53%,死亡年龄中位数[范围]81[53-102]岁)。
  • 较年轻症状起病(Spearman ρ=0.39,P<.001)和简易精神状态检查更快下降(Spearman ρ=0.27,P<.001)与较低CLix评分相关。
  • 非遗忘型综合征患者CLix评分中位数[IQR]为13[9-18],低于非非遗忘型患者的21[15-27](P<.001)。
  • 海马MRI体积(Spearman ρ=-0.45,P<.001)及后扣带回和楔前叶皮质flortaucipir tau-PET摄取(Spearman ρ=-0.74,P<.001)与CLix评分呈负相关。
  • CLix评分小于10的AD病例皮质缠结计数较高,但CD68激活小胶质细胞/巨噬细胞负担百分比中位数[IQR]为0.46%[0.32%-0.75%],低于CLix评分10至30者的0.75%[0.51%-0.98%],与CLix评分30或以上者的0.40%[0.32%-0.57%]相当(P=.02)。

关键数值与推荐

  • CLix评分较低代表相对皮质为主/海马保留型,较高代表相对皮质保留/边缘系统为主型。
  • CLix评分小于10组CD68负担中位数[IQR]0.46%[0.32%-0.75%],CLix评分10至30组0.75%[0.51%-0.98%],CLix评分30或以上组0.40%[0.32%-0.57%](P=.02)。
  • 非遗忘型综合征CLix评分中位数[IQR]13[9-18],非非遗忘型21[15-27](P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Factors associated with clinical heterogeneity in Alzheimer disease (AD) lay along a continuum hypothesized to associate with tangle distribution and are relevant for understanding glial activation considerations in therapeutic advancement. OBJECTIVES: To examine clinicopathologic and neuroimaging characteristics of disease heterogeneity in AD along a quantitative continuum using the corticolimbic index (CLix) to account for individuality of spatially distributed tangles found at autopsy. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study was a retrospective medical record review performed on the Florida Autopsied Multiethnic (FLAME) cohort accessioned from 1991 to 2020. Data were analyzed from December 2022 to December 2023. Structural magnetic resonance imaging (MRI) and tau positron emission tomography (PET) were evaluated in an independent neuroimaging group. The FLAME cohort includes 2809 autopsied individuals; included in this study were neuropathologically diagnosed AD cases (FLAME-AD). A digital pathology subgroup of FLAME-AD cases was derived for glial activation analyses. MAIN OUTCOMES AND MEASURES: Clinicopathologic factors of heterogeneity that inform patient history and neuropathologic evaluation of AD; CLix score (lower, relative cortical predominance/hippocampal sparing vs higher, relative cortical sparing/limbic predominant cases); neuroimaging measures (ie, structural MRI and tau-PET). RESULTS: Of the 2809 autopsied individuals in the FLAME cohort, 1361 neuropathologically diagnosed AD cases were evaluated. A digital pathology subgroup included 60 FLAME-AD cases. The independent neuroimaging group included 93 cases. Among the 1361 FLAME-AD cases, 633 were male (47%; median [range] age at death, 81 [54-96] years) and 728 were female (53%; median [range] age at death, 81 [53-102] years). A younger symptomatic onset (Spearman ρ = 0.39, P < .001) and faster decline on the Mini-Mental State Examination (Spearman ρ = 0.27; P < .001) correlated with a lower CLix score in FLAME-AD series. Cases with a nonamnestic syndrome had lower CLix scores (median [IQR], 13 [9-18]) vs not (median [IQR], 21 [15-27]; P < .001). Hippocampal MRI volume (Spearman ρ = -0.45; P < .001) and flortaucipir tau-PET uptake in posterior cingulate and precuneus cortex (Spearman ρ = -0.74; P < .001) inversely correlated with CLix score. Although AD cases with a CLix score less than 10 had higher cortical tangle count, we found lower percentage of CD68-activated microglia/macrophage burden (median [IQR], 0.46% [0.32%-0.75%]) compared with cases with a CLix score of 10 to 30 (median [IQR], 0.75% [0.51%-0.98%]) and on par with a CLix score of 30 or greater (median [IQR], 0.40% [0.32%-0.57%]; P = .02). CONCLUSIONS AND RELEVANCE: Findings show that AD heterogeneity exists along a continuum of corticolimbic tangle distribution. Reduced CD68 burden may signify an underappreciated association between tau accumulation and microglia/macrophages activation that should be considered in personalized therapy for immune dysregulation.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Kouri N, Frankenhauser I, Peng Z, et al. Clinicopathologic Heterogeneity and Glial Activation Patterns in Alzheimer Disease. JAMA Neurol. 2024. PMID: 38619853. doi:10.1001/jamaneurol.2024.0784

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。